Structure validation of the Josephin domain of ataxin-3: Conclusive evidence 
for an open conformation

Nicastro, G; Habeck, M; Masino, L; Svergun, DI; Pastore, A

doi:10.1007/s10858-006-9092-z

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Structure validation of the Josephin domain of ataxin-3: Conclusive evidence for an open conformation

MPS-Authors

/persons/resource/persons83949

Habeck, M
Department Empirical Inference, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

https://link.springer.com/content/pdf/10.1007%2Fs10858-006-9092-z.pdf
(出版社版)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Nicastro, G., Habeck, M., Masino, L., Svergun, D., & Pastore, A. (2006). Structure validation of the Josephin domain of ataxin-3: Conclusive evidence for an open conformation. Journal of Biomolecular NMR, 36(4), 267-277. doi:10.1007/s10858-006-9092-z.

引用: https://hdl.handle.net/11858/00-001M-0000-0013-CF43-8

要旨

The availability of new and fast tools in structure determination has led to a more than exponential growth of the number of structures solved per year. It is therefore increasingly essential to assess the accuracy of the new structures by reliable approaches able to assist validation. Here, we discuss a specific example in which the use of different complementary techniques, which include Bayesian methods and small angle scattering, resulted essential for validating the two currently available structures of the Josephin domain of ataxin-3, a protein involved in the ubiquitin/proteasome pathway and responsible for neurodegenerative spinocerebellar ataxia of type 3. Taken together, our results demonstrate that only one of the two structures is compatible with the experimental information. Based on the high precision of our refined structure, we show that Josephin contains an open cleft which could be directly implicated in the interaction with polyubiquitin chains and other partners.